Furthermore, a distinct subgroup of tumor-infiltrating lymphocytes (TILs), PD1+CXCL13+CD8+T cells was found to localize with TLS and exhibited enhanced anti-tumor effects. This evidence concerns the gene CD8A and neoplasm.